The association between maternal urinary phthalate concentrations and blood pressure in pregnancy: The HOME Study
Open Access
- 17 September 2015
- journal article
- research article
- Published by Springer Science and Business Media LLC in Environmental Health
- Vol. 14 (1), 1-9
- https://doi.org/10.1186/s12940-015-0062-3
Abstract
Exposure to phthalates, a class of endocrine disrupting chemicals, is ubiquitous. We examined the association of urinary phthalate metabolite concentrations during pregnancy with maternal blood pressure and risk of pregnancy-induced hypertensive diseases. We used data from the Health Outcomes and Measures of the Environment Study, a prospective birth cohort of low-risk pregnant women recruited between March 2003 and January 2006. We analyzed maternal urine samples collected at 16 and 26 weeks gestation for 9 phthalate monoester metabolites reflecting exposure to 6 phthalate diesters. Outcomes included maternal blood pressure at <20 and ≥20 weeks gestation and pregnancy induced hypertensive diseases (gestational hypertension, preeclampsia, eclampsia, and HELLP syndrome). Data were available for 369 women who gave birth to singleton, live-born infants without congenital anomalies. Of the phthalate metabolites evaluated, only mono-benzyl phthalate (MBzP) concentrations were significantly associated with maternal diastolic blood pressure at <20 weeks gestation. Women in the third MBzP tercile at 16 weeks gestation had diastolic blood pressure 2.2 (95 % CI: 0.5–3.9) mm Hg higher at <20 weeks gestation and 2.8 (95 % CI: 0.9–4.7) mm Hg higher at ≥20 weeks gestation compared to women in the first tercile. Compared to women in the first tercile, women in the top MBzP tercile at 16 weeks had an increased risk of developing pregnancy-induced hypertensive diseases (RR = 2.92, 95 % CI 1.15–7.41, p-value for trend = 0.01). MBzP concentrations at 26 weeks gestation were not as strongly associated with blood pressure at ≥20 weeks gestation or risk of pregnancy-induced hypertensive diseases. This study suggests that maternal urinary MBzP concentrations may be associated with increased diastolic blood pressure and risk of pregnancy-induced hypertensive diseases.Keywords
This publication has 18 references indexed in Scilit:
- Environmental Pollutants and Hydroxysteroid DehydrogenasesVitamins & Hormones, 2014
- Urinary Phthalates Are Associated with Higher Blood Pressure in ChildhoodThe Journal of Pediatrics, 2013
- Can changes in angiogenic biomarkers between the first and second trimesters of pregnancy predict development of pre‐eclampsia in a low‐risk nulliparous patient population?BJOG: An International Journal of Obstetrics and Gynaecology, 2013
- Thyroid effects of endocrine disrupting chemicalsMolecular and Cellular Endocrinology, 2012
- Variability of Urinary Phthalate Metabolite and Bisphenol A Concentrations before and during PregnancyEnvironmental Health Perspectives, 2012
- Urinary phthalate metabolites in relation to biomarkers of inflammation and oxidative stress: NHANES 1999–2006Environmental Research, 2011
- Environmental Chemicals in Pregnant Women in the United States: NHANES 2003–2004Environmental Health Perspectives, 2011
- What Additional Factors Beyond State-of-the-Art Analytical Methods Are Needed for Optimal Generation and Interpretation of Biomonitoring Data?Environmental Health Perspectives, 2009
- Phthalates and Children’s HealthCurrent Problems in Pediatric and Adolescent Health Care, 2008
- Gestational and Lactational Exposure to Ethinyl Estradiol, but not Bisphenol A, Decreases Androgen-Dependent Reproductive Organ Weights and Epididymal Sperm Abundance in the Male Long Evans Hooded RatToxicological Sciences, 2007